Genetic polymorphisms of the TYMS gene are not associated with congenital cardiac septal defects in a Han Chinese population

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Zhao, Jian Yuan ^a,d   Sun, Jing Wei ^a   Gu, Zhuo Ya ^a   Wang, Jue ^a   Wang, Er Li ^a   Yang, Xue Yan ^a   Qiao, Bin ^b   Duan, Wen Yuan ^b   Huang, Guo Ying ^c   Wang, Hong Yan ^a,c  

^a FUDAN UNIVERSITY   (China)

^b Institute of Cardiovascular Disease General Hospital   (China)

^c FUDAN UNIVERSITY   (China)

^d Institute of Sports Science and Technology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDYLATE SYNTHASE; DNA; HOMOCYSTEINE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ARTICLE; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEART SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRESCHOOL CHILD; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TYMS GENE; BLOOD; CATALYSIS; CHEMISTRY; CHINA; ETHNOLOGY; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; METABOLISM;

CASE-CONTROL STUDIES; CATALYSIS; CHILD; CHILD, PRESCHOOL; CHINA; DNA; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; HEART SEPTAL DEFECTS; HOMOCYSTEINE; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PURINES; PYRIMIDINES; THYMIDYLATE SYNTHASE;

EID: 84863147217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031644     Document Type: Article

References (26)

1. Hoffman JIE, Kaplan S, (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39: 1890-1900.
2. Botto LD, Mulinare J, Erickson JD, (2003) Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet A 121: 95-101.
3. Botto LD, Khoury MJ, Mulinare J, Erickson JD, (1996) Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study. Pediatrics 98: 911-7.
4. Botto LD, Olney RS, Erickson JD, (2004) Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C 125: 12-21.
5. Bailey LB, Berry RJ, (2005) Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 81: 1213-7S.
6. Huhta JC, Linask K, Bailey L, (2006) Recent advances in the prevention of congenital heart disease. Curr Opin Pediatr 18: 484-9.
7. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, et al. (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014.
8. Huhta JC, Hernandez-Robles JA, (2005) Homocysteine, folate, and congenital heart defects. Fetal Pediatr Pathol 24: 71-9.
9. Lupo PJ, Mitchell LE, Goldmuntz E, (2011) NAT1, NOS3, and TYMS Genotypes and the Risk of Conotruncal Cardiac Defects. Birth Defects Res A 91: 61-5.
10. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA, (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343: 1608-14.
11. Hobbs CA, Cleves MA, Karim MA, Zhao W, Macleod SL, et al. (2010) Maternal Folate-Related Gene Environment Interactions and Congenital Heart Defects. Obstet Gynecol 116: 316-22.
12. Van Beynum IM, Kouwenberg M, Kapusta L, den Heijer M, van der Linden IJ, et al. (2006) MTRR 66A>G polymorphism in relation to congenital heart defects. Clin Chem Lab Med 44 (11): 1317-23.
13. Van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, et al. (2006) Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 27 (8): 981-7.
14. Kim SR, Ozawa S, Saito Y, Kurose K, Kaniwa N, et al. (2006) Fourteen Novel Genetic Variations and Haplotype Structure of the TYMS Gene Encoding Human Thymidylate Synthase (TS). Drug Metab Pharmacokinet 21 (6): 509-16.
15. Shaw GM, Lu W, Zhu H, Yang W, Briggs FBS, et al. (2009) 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet 10: 49.
16. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW, (2002) Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111 (3): 299-302.
17. Wilding CS, Relton CL, Sutton MJ, Jonas PA, Lynch SA, et al. (2004) Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the Northern United Kingdom. Birth Def Res A 70 (7): 483-5.
18. Volcik KA, Shaw GM, Zhu H, Lammer EJ, Laurent C, et al. (2003) Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A 67 (11): 924-8.
19. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD, (2002) Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res 62 (12): 3361-4.
20. Kawate H, Landis DM, Loeb LA, (2002) Distribution of mutations in human thymidylate synthase yielding resistance to 5-fluoro-deoxyuridine. J Biol Chem 277 (39): 36304-11.
21. Sole X, Guino E, Valls J, Iniesta R, Moreno V, (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22 (15): 1928-9.
22. Blanton SH, Henry RR, Yuan Q, Mulliken JB, Stal S, et al. (2011) Folate Pathway and Nonsyndromic Cleft Lip and Palate. Birth Defects Res A 91: 50-60.
23. Kaneda S, Nalbantoglu J, Takeishi K, Shimizut K, Gotoh O, et al. (1990) Structural and Functional Analysis of the Human Thymidylate Synthase Gene. J Biol Chem 265: 20277-84.
24. Kaneda S, Horie N, Takeishi K, Takayanagi A, Seno T, et al. (1992) Regulatory sequences clustered at the 5′ end of the first intron of the human thymidylate synthase gene function in cooperation with the promoter region. Somat Cell Mol Genet 18: 409-15.
25. Takayanagi A, Kaneda S, Ayusawa1 D, Seno T, (1992) Intron 1 and the 5′-flanking region of the human thymidylate synthase gene as a regulatory determinant of growth-dependent expression. Nucleic Acids Res 20: 4021-5.
26. Ayusawaa D, Shimizua K, Koyamab H, Kanedaa S, Takeishia K, et al. (1986) Cell-cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibroblasts stimulated to proliferate. J Mol Biol 190: 559-67.